CellWell record HH-526288
Bimodal Fluorescent Conjugate Based on Prostate-Specific Membrane Antigen Ligands with the Chelating Agent DOTA and SulfoCy5 Dye: Synthesis, Radiolabeling, and Biological Activity
A. Machulkin; S. A. Petrov; N. S. Butakova; A. S. Lunev; K. A. Petrosova; R. Shafikov; Dmitry A. Skvortsov; I. Mitrofanov; Mariia N. Ivashkovaskaia; E. Beloglazkina; A. A. Larenkov
International Journal of Molecular Sciences ยท 2026
In plain language
A DOTA-linked, SulfoCy5-labeled PSMA ligand conjugate showed tumor-cell visualization comparable to a reference compound and reduced renal accumulation compared with a dye-free conjugate in mice.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-526288
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.